Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
Maya R Chilbert,1,2 Dylan VanDuyn,3 Sara Salah,1 Collin M Clark,1,2 Qing Ma1 1Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA; 2Department of Pharmacy, Buffalo General Medical Center, Buffalo, NY, USA; 3Department of Pharmacy,...
Main Authors: | Chilbert MR, VanDuyn D, Salah S, Clark CM, Ma Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-07-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/combination-therapy-of-ezetimibe-and-rosuvastatin-for-dyslipidemia-cur-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Features of using of a fixed combination of rosuvastatin and ezetimibe for effective hypolipidemic therapy
by: I. A. Alekseeva, et al.
Published: (2020-10-01) -
Office Management of Dyslipidemia
by: Gary Tabas, et al.
Published: (2010-03-01) -
The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
by: Suleiman Ehab S, et al.
Published: (2004-10-01) -
Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian State of Rio de Janeiro
by: Souza Luiz José de, et al.
Published: (2003-01-01) -
Dyslipidemia Exacerbates Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
by: Yasufumi Tomioka, et al.
Published: (2023-03-01)